Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors and α and β

Endocrinology

Volumn 138, Issue 3, 1997, Pages 863-870

  Kuiper, George G J M ^a   Carlsson, Bo ^b   Grandien, Kaj ^a   Enmark, Eva ^a   Häggblad, Johan ^b   Nilsson, Stefan ^b   Gustafsson, Jan Åke ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Karo Bio   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; RECEPTOR SUBTYPE;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN; DISSOCIATION CONSTANT; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; HYPOPHYSIS; KIDNEY; LIGAND BINDING; LUNG; NONHUMAN; OVARY; PRIORITY JOURNAL; PROSTATE; PROTEIN DETERMINATION; RAT; RECEPTOR AFFINITY; TESTIS; TISSUE DISTRIBUTION; UTERUS;

EID: 0031039888     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.3.4979     Document Type: Article

References (45)

1. Clark JH, Schrader WT, O'Malley BW 1992 Mechanisms of action of steroid hormones. In: Wilson J, Foster DW (eds) Textbook of Endocrinology. WB Saunders Company, Philadelphia, pp 35-90
2. Murdoch FE, Gorski J 1991 The role of ligand in estrogen receptor regulation of gene expression. Mol Cell Endocrinol 78:C103-C108
3. Koike S, Sakai M, Muramatsu M 1987 Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res 15:2499-2513
4. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JÅ 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
5. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS 1996 Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10:119-131
6. Gronemeyer H, Laudet V 1995 Transcription factors 3: nuclear receptors. Protein Profiles 2:1173-1305
7. Seielstad DA, Carleon KE, Kushner PJ, Greene GL, Katzenellenbogen JA 1995 Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis. Biochemistry 34:12605-12615
8. Korach KS, Migliaccio S, Davis VL 1995 Estrogens. In: Munson PL (ed) Principles of Pharmacology. Basic Concepts and Clinical Applications. Chapman and Hall, New York, pp 809-825
9. Jordan VC 1995 Antiestrogens. In: Munson PL (ed) Principles of Pharmacology. Basic Concepts and Clinical Applications. Chapman and Hall, New York, pp 827-836
10. Grainger DJ, Metcalfe JC 1996 Tamoxifen: teaching an old drug new tricks? Nature Med 2:381-385
11. Beekman JM, Allan GF, Tsai SY, Tsai M-J, O'Malley BW 1993 Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol 7:1266-1272
12. Salomonsson M, Carlsson B, Häggblad J 1994 Equilibrium hormone binding to human estrogen receptors in highly diluted cell extracts is non-cooperative and has a Kd of approximately 10 pM. J Steroid Biochem Mol Biol 50:313-318
13. Wells JW 1992 Analysis and interpretation of binding at equilibrium. In: Hulme EC (ed) Receptor Ligand Interactions. A Practical Approach. IRL Press, Oxford UK, pp 289-397
14. Hulme EC, Birdsall NJM 1992 Strategy and tactics in receptor-binding studies. In: Hulme EC (ed) Receptor Ligand Interactions. A Practical Approach. IRL Press, Oxford UK, pp 163-176
15. Schults JR, Ruppel PI, Johnson MA 1988 Pharmaceutical lead discovery and optimization. In: Peace KE (ed) Biopharmaceutical Statistics for Drug Development. Marcel Dekker, New York, pp 21-82
16. Chomczynski P, Sacchi N 1987 Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
17. Grandien K, Bäckdahl M, Ljunggren Ö, Gustafsson J-Å, Berkenstam A 1995 Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology 136:2223-2229
18. Grandien KFH, Berkenstam A, Nilsson S, Gustafsson JÅ 1993 Localization of DNase I hypersensitive sites in the human oestrogen receptor gene correlates with the rranscriptional activity of two differentially used promoters. J Mol Endocrinol 10:269-277
19. 125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins. Proc Natl Acad Sci USA 77:328-332
20. 125I]-oestradiol. Histochem J 17:1185-1196
21. Noteboom WD, Gorski J 1965 Stereospecific binding of estrogens in the rat uterus. Arch Biochem Biophys 111:559-568
22. Hähnel R, Twaddle E, Ratajczak T 1973 The specificity of the estrogen receptor of human uterus. J Steroid Biochem 4:21-31
23. Pieslor PC, Gibson RE, Eckelman WC, Oates KK, Cook B, Reba RC 1982 Three radioligands compared for determining cytoplasmic estrogen receptor content of human breast carcinomas. Clin Chem 28:532-537
24. Wakeling AE 1996 Physiological effects of pure antiestrogens. In: Katzenellenbogen BS, Pasqualini JR (eds) Hormone-Dependent Cancer. Marcel Dekker, New York, pp 107-118
25. Huggins CV, Jensen EV, Cleveland AS 1954 Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat. J Exp Med 100:225-236
26. 3H-labeled androgens to the estrogen receptor. Endocrinology 104:1797-1804
27. van Doom LG, Poortman J, Thijssen JHH, Schwarz F 1981 Actions and interactions of 5-androstene-3β,17β-diol and 17β-estradiol in the immature rat uterus. Endocrinology 108:1587-1593
28. Botella J, Duranti E, Viader V, Duc I, Delansorne R, Paris J 1995 Lack of estrogenic potential of progesterone or 19-Nor-progesterone-derived progestins as opposed to testosterone or 19-Nor-testosterone derivatives on endometrial Ishikawa cells. J Steroid Biochem Mol Biol 55:77-84
29. Mäkelä, S, Davis VL, Tally W, Korkman J, Salo L, Vihko R, Santti R, Korach K 1994 Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 102:572-581
30. Adlercreutz H, Markkanen H, Watanabe S 1993 Plasma concentrations of phyto-estrogens in Japanese men. Lancet 342:1209-1210
31. Katzenellenbogen BS, Katzenellenbogen J, Mordecai D 1979 Zearalenones: characterization of the estrogenic potenties and receptor interactions of a series of fungal β-resorcylic add lactones. Endocrinology 105:33-40
32. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM 1995 Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 375:581-585
33. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guilette LJ, McLachlan JA 1996 Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272:1489-1492
34. van Beurden-Lamers WMO, Brinkmann AO, Mulder E, van der Molen HJ 1974 High-affinity binding of oestradiol-17β by cytosols from testis interstitial tissue, pituitary, adrenal, liver and accessory sex glands of the male rat. Biochem J 140:495-502
35. Morishige WK, Uetake C-A 1978 Receptors for androgen and estrogen in the rat lung. Endocrinology 102:1827-1836
36. Notides AC 1970 Binding affinity and specificity of the estrogen receptor of the rat uterus and anterior pituitary. Endocrinology 87:987-992
37. Swillens S, Waelbroeck M, Champeil P 1995 Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites? Trends Pharmaceutical Sci 16:151-155
38. Prins GS, Birch L 1995 The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136:1303-1314
39. Brolin J, Skoog L, Ekman P 1992 Immunohistochemistry and biochemistry in detection of androgen, progesterone and estrogen receptors in benign and malignant human prostatic tissues. Prostate 20:281-295
40. Kudolo GB, Elder MG, Myatt L 1984 A novel oestrogen-binding species in rat granulosa cells. J Endocrinol 102:83-91
41. Hild-Petito S, Stouffer RL, Brenner RM 1988 Immuno-cytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology 123:2896-2904
42. Greene GL, Jensen EV 1982 Monoclonal antibodies as probes for estrogen receptor detection and characterization. J Steroid Biochem 16:353-359
43. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162-11166
44. Merchenthaler I, Shughrue PJ, Lubahn DB, Negro-Vilar A, Korach KS 1996 Estrogen responses in estrogen receptor-disrupted mice: an in vivo autoradiographic and in situ hybridization study. Program of the 10th International Congress of Endocrinology, San Francisco, CA, 1996, p 744 (Abstract)
45. Blaustein JD 1992 Cytoplasmic estrogen receptor in rat brain: immuno-cytochemical evidence using three antibodies with distinct epitopes. Endocrinology 131:1336-1342